ZLZuo-Lin Li

Zuo-Lin Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zuo-Lin Li has a total of 124 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tubular tRF‑1:30‑Gln‑CTG‑4 attenuates tubulointerstitial fibrosis by mitigating FBXO7-mediated mitophagy defect in diabetic kidney disease

    by Jia-Ling Ji, Yun-Yang Qiao, Jia-Yue Sun, Ying Huo, Hui-Min Shi, Gao-Ting Qu, Shan-Wen Li, Chan Huang, Yu Feng, Pei Zhang, et al.

    Tubulointerstitial fibrosis (TIF) is a crucial pathological feature and inevitable consequence of progressive diabetic kidney disease (DKD). Transfer RNA-derived fragments (tRFs), a novel class of small non-coding RNA by cleavage of tRNAs, have recently attracted attention due to their functional significance in diverse biological processes. However, the role of tRFs in TIF is largely elusive. In the present study, we found that a tRF, tRF‑1:30‑Gln‑CTG‑4, was markedly decreased in proximal renal tubules and highly correlated with TIF in DKD mice. The overexpression of tRF‑1:30‑Gln‑CTG‑4 revealed a therapeutic effect against TIF. Further, RNA pull-down and RNA-immunoprecipitation assay were performed to identify that FBXO7, an adaptor protein in the SCF E3 ligase complex, was the targeted protein of tRF‑1:30‑Gln‑CTG‑4. Mass spectrometry and co-immunoprecipitation experiments revealed that PINK1, a master mitophagy-regulating protein, acted as the substrate of FBXO7 in tubular epithelial cells. Mechanistically, elevated FBXO7 promoted mitophagy defect through mediating PINK1 ubiquitylation and proteasomal degradation. The overexpression of tRF‑1:30‑Gln‑CTG‑4 alleviated defective mitophagy. Taken together, this study not only represents a novel insight into the pathogenesis of TIF but also provides a promising therapeutic targeting for the delaying the progression of DKD.

  • Open Access

    Differential Associations of Iron Deficiency with Renal Progression and Mortality in Anemic Non-Dialysis-Dependent Chronic Kidney Disease

    by Wen-Cong Guo, Li-Cong Su, Bin Wang, Zuo-Lin Li, Min Wu, Feng-Mei Wang, Yi Wen, Meng-Chun Gong, Fan-Fan Hou, Bi-Cheng Liu

    Introduction: Iron deficiency is prevalent in chronic kidney disease (CKD), particularly among patients with anemia. However, the prognostic value of routinely measured iron biomarkers, ferritin and transferrin saturation (TSAT), in non-dialysis-dependent (NDD) CKD remains incompletely defined. Methods: We conducted a multicenter retrospective cohort study using data from the China Renal Data System. Eligible hospitalized adults had anemia and NDD-CKD with baseline serum ferritin or TSAT measurements. Iron deficiency was defined as ferritin ≤100 ng/mL and/or TSAT ≤20%. The primary outcomes were CKD progression and all-cause mortality. Associations were assessed using multivariable Cox proportional hazards models; Fine and Gray competing risk models and prespecified subgroup analyses evaluated robustness. Results: Among 40,667 patients with anemic CKD, 38,307 had ferritin measurements, and 9,210 had TSAT measurements. Of these, 11,116 (29.02%) had ferritin ≤100 ng/mL and 3,295 (35.78%) had TSAT ≤20%. During follow-up, CKD progression occurred in 8,756 (22.85%) patients in the ferritin cohort and 2,459 (26.70%) in the TSAT cohort. In multivariable analyses, ferritin ≤100 ng/mL was associated with a modestly lower risk of CKD progression than levels greater than 100 ng/mL (adjusted hazard ratio [aHR], 0.95; 95% confidence interval [CI], 0.90-0.99), with similar results in competing-risk analyses. TSAT ≤20% was not associated with CKD progression (aHR, 1.04; 95% CI, 0.95-1.13). For all-cause mortality, ferritin ≤100 ng/mL was not independently associated with risk (aHR, 0.99; 95% CI, 0.93-1.06), whereas TSAT ≤ 20% was associated with higher risk (aHR, 1.19; 95% CI, 1.06-1.36). CRP stratified analyses indicated that ferritin ≤100 ng/mL was associated with lower CKD progression risk only among patients with CRP ≤10 mg/L, suggesting that the prognostic association of ferritin varied by inflammatory status. Conclusion: In Chinese adults with anemia and NDD-CKD, ferritin and TSAT showed divergent prognostic associations. TSAT ≤ 20% identified higher mortality risk, whereas ferritin ≤ 100 ng/mL was associated with a modestly lower observed risk of CKD progression in an inflammation-dependent pattern. These findings support routine, context aware assessment of iron indices, particularly TSAT, in anemic NDD-CKD.

  • Top Cited Papers

    Neutrophil extracellular traps drive tubulointerstitial fibrosis via the coiled‐coil domain‐containing protein 25 (CCDC25)–Yes‐associated protein 1 (YAP1) axis‐mediated autophagy regulation

    by Xinhui Hu, Weijie Ni, Haifei Liu, Zuolin Li, Jing Wang, Yuan Lu, Bin Wang, Hong Liu, Jingyuan Cao

    Background and Purpose: Tubulointerstitial fibrosis (TIF) is a pathological hallmark of chronic kidney disease (CKD) without effective therapy. Neutrophil extracellular traps (NETs) are complex web‐like structures released by activated neutrophils, but their functional contribution to CKD–TIF remains largely unknown. Here, we uncovered a novel pathological role of NETs in driving TIF development. Experimental Approach: NETs levels were evaluated in human kidney biopsies and serum samples. Peptidylarginine deiminase 4 (PAD4) knockout mice were subjected to unilateral ureteral obstruction and adenine‐induced nephropathy models. The underlying mechanisms were elucidated by RNA sequencing, transmission electron microscopy, molecular docking and co‐immunoprecipitation. The PAD4 inhibitor GSK484 was administered to evaluate the role of NETs in TIF. Key Results: NETs markedly accumulated in kidneys of CKD patients and murine models, positively correlating with renal dysfunction and fibrosis progression. PAD4 knockout suppressed NETs formation and attenuated TIF. Mechanistically, transcriptomic analyses displayed pronounced activation of autophagy‐related pathways in NETs‐stimulated fibroblasts, whereas autophagy inhibition suppressed fibroblast activation. NETs components interacted with the transmembrane receptor coiled‐coil domain‐containing protein 25 (CCDC25), triggering dissociation of Yes‐associated protein 1 (YAP1) from its receptor. This molecular rearrangement facilitates YAP1 nuclear translocation, subsequently enhancing autophagic activity in fibroblasts and promoting their phenotypic transition into myofibroblasts. Therapeutic administration of the PAD4 inhibitor GSK484 significantly attenuated renal fibrosis in vivo. Conclusions and Implications: Our study provides the first evidence that NETs exacerbate CKD–TIF by enhancing fibroblast autophagy via the CCDC25–YAP1 axis, highlighting the NETs inhibitor GSK484 as a promising therapeutic candidate.


  • Open Access

    T Cell‐Independent Role of PD‐L1 in Kidney Repair: Mitigation of Tubular DNA Damage via PD‐L1/BRCA1 Interaction Following AKI

    by Wei Jiang, Tao‐Tao Tang, Wei‐Jie Ni, Jin‐Xuan Wei, Liang‐Yun‐Zi Jiang, Qing Yin, Yi‐Lin Zhang, Zuo‐Lin Li, Yi Wen, Xin‐Lu Wang, et al.

    Acute kidney injury (AKI) occurs in the patients undergoing anti‐programmed cell death protein 1‐ligand 1 (PD‐L1) therapy, indicating that PD‐L1 may play a critical role in maintaining renal homeostasis. However, the precise role and mechanism of PD‐L1 in AKI remains largely elusive. In this study, we found that PD‐L1 was primarily expressed in proximal tubules and significantly upregulated in both murine models of AKI and renal biopsy samples from AKI patients. Genetic specific deletion of PD‐L1 in mouse tubular epithelial cells (TECs) exacerbated renal injury in ischemia‐reperfusion injury‐induced AKI. Mechanistically, PD‐L1 was found to interact with BRCA1 and increase BRCA1 expression to safeguard TECs against DNA damage, thereby promoting cellular proliferation and suppressing apoptosis. To translate these findings into a potential therapeutic strategy, we developed a CGA‐functionalized extracellular vesicle delivery system for targeted delivery of PD‐L1 to injured TECs. This system efficiently restored PD‐L1 expression and alleviated DNA damage of TECs in both TEC‐specific PD‐L1 knockdown and T‐cell knockout AKI mouse models. Collectively, these findings uncover a novel function of PD‐L1 in promoting adaptive TEC repair through BRCA1 interaction, independent of its canonical immunomodulatory function of T cells, and suggest that PD‐L1 supplementation may represent a promising therapeutic strategy for AKI.


  • Open Access

    Prevalence and Genetic Spectrum of Inherited Kidney Diseases

    by Ziqi Liu, Jing Zhuang, Yan Yang, Ailima Aierken, Fengmei Wang, Zuolin Li, Qing Yin, Yan Tu, Hong Jiang, Bin Wang

    Background: Inherited Kidney Disease (IKD) significantly contributes to CKD in children, adolescents, and adults. However, large-scale research on the prevalence of IKD in a Chinese population is currently lacking. To address this gap, we use exome sequencing (ES) to thoroughly investigate the prevalence and disease spectrum of IKD in a Chinese population. Methods: ES was conducted on 290 patients with kidney disease of unknown etiology from two centers. Genetic test results were interpreted following the American College of Medical Genetics and Genomics (ACMG) guidelines and the criteria for Variants of Uncertain Significance (VUS). Clinical data were integrated to establish a definitive diagnosis. Results: 290 patients from 261 families were included in this study. Diagnostic variants were identified in 82 families, yielding a diagnostic rate of 31% (82/261). Six genes ( PKD1 , PKD2 , COL4A3 , COL4A4 , COL4A5 , and UMOD ) accounted for 50% (41/82) of diagnosed cases. Ciliopathies were the most common subtype, followed by tubulopathies, collagenopathies, and podocytopathies. The diagnostic rate was higher in the age groups of ≤20 years and ≥41 years, at 63% and 39%, respectively. Among 51 biopsied patients, glomerular lesions (34/51) were the most common pathological type, followed by tubulointerstitial lesions (11/51). Of the 14 genetic diagnoses, 12 (86%) were consistent with histopathologic findings. Conclusions: A molecular genetic diagnosis was achieved in 31% of selected Chinese families. Genetic and clinical diagnosis complement each other, highlighting the application value of genetic testing in the diagnosis of IKD.


  • Oxaloacetate Restores HIF ‐1α‐Mediated Mitochondrial Homeostasis to Counter Tubulointerstitial Injury in Diabetic Kidney Disease

    by Yao Zhang, Jia‐Ling Ji, Dan‐Dan Yao, Yan Zhou, Cong‐Cong Liu, Zhen‐Lin Tang, Jia‐Le Xue, Bi‐Cheng Liu, Zuo‐Lin Li, Rui‐Xia Ma

    Background: Renal tubular injury, one of the most critical events in diabetic kidney disease (DKD), plays a pivotal role in the progression of the disease. Metabolic reprogramming of renal tubular cells emerges as a prominent pathological feature, yet its underlying molecular mechanisms remain incompletely understood. Methods: We established a streptozotocin‐induced mouse model of diabetes. Metabolomic analysis was then used to characterise DKD‐specific metabolic alterations. To test the functional consequence of a metabolic intervention, DKD mice received intraperitoneal injections of oxaloacetate (OAA). Furthermore, molecular docking and cellular thermal shift assays were used to elucidate the molecular mechanisms underlying OAA's effects on renal tubular injury, which were further validated in HK‐2 cells exposed to high glucose. Finally, a specific pharmacological inhibitor was applied to study the relevant signalling pathway. Results: Metabolomic profiling identified a marked decrease in OAA, a key tricarboxylic acid (TCA) cycle intermediate, in injured renal tubular cells. OAA supplementation significantly attenuated tubulointerstitial injury, as evidenced by reduced tubular cell damage, fibrosis, and macrophage infiltration. Moreover, restored mitochondrial homeostasis was observed in DKD mice after OAA treatment. Mechanistically, we found that OAA inhibited prolyl hydroxylase domain 2 (PHD2), an essential regulator of hypoxia‐inducible factor‐1α (HIF‐1α), thereby stabilising mitochondrial homeostasis. Furthermore, pharmacological inhibition of HIF‐1α abolished the protective effects of OAA, confirming the involvement of the PHD2/HIF‐1α axis. Conclusions: OAA ameliorates renal tubulointerstitial injury in DKD by restoring mitochondrial homeostasis through the PHD2/HIF‐1α axis.


  • Top Cited Papers
    Open Access

    Roxadustat for renal anemia: current clinical experience

    by Jialing Ji, Zhongtang Li, Shuping Fang, Zuolin Li

    Anemia represents one of the most prevalent complications of chronic kidney disease (CKD). Investigation of the regulation of erythropoietin production led to the discovery of oxygen-sensing mechanisms, which are now being targeted therapeutically (hypoxia-inducible factor prolyl hydroxylase inhibitors, HIF-PHI). Roxadustat, a first-in-class of HIF-PHI, achieved its first approval in China in December 2018 for managing anemia in adult patients with CKD. Over the past 6 years, we have gained substantial real-world experience regarding its therapeutic application. Accordingly, accumulated evidence demonstrates that roxadustat is superior to placebo and non-inferior to current standard-of-care erythropoiesis-stimulating agents in correcting and maintaining hemoglobin concentration at target levels among patients with non-dialysis dependent CKD and incident and dialysis dependent CKD. However, given the pleiotropic effects of HIF activation, the pharmacologic activation of HIF in patients with anemia of CKD is also likely to have effects beyond erythropoiesis and iron metabolism. In this review, we synthesize clinical insights from these novel therapeutics and highlight some of the outstanding questions relevant to their clinical use. This study may provide theoretical framework and practical evidence for the clinical application of other HIF-PHIs.


  • Open Access

    ATF4 promotes renal tubulointerstitial fibrosis through hexokinase II-mediated glycolysis

    by Songtao Feng, Yueming Gao, Zheng Wang, Weijie Ni, Yan Zhou, Mingyue Yuan, Jinyang Ge, Lu Sun, Bicheng Liu, Hui Qian, et al.

    Background: Renal tubulointerstitial fibrosis is a reliable predictor of progressive chronic kidney disease (CKD). Activating transcription factor 4 (ATF4) has recently emerged as a pivotal player in multiple pathophysiologic processes, particularly the stress response processes. This study aims to explore the role of ATF4 in tubulointerstitial fibrosis from a metabolic perspective. Methods: A murine model of renal fibrosis was generated via unilateral ureteral obstruction (UUO). Quantitative PCR was employed to assess the expression of inflammation-related genes and fibrotic markers in renal tissue, while Western blotting was used to quantify the corresponding protein levels. Immunohistochemistry was performed to determine the localization and expression patterns of ATF4. Lentivirus-mediated ATF4 knockdown mice, along with mice subjected to glycolytic inhibition, were subsequently employed to further investigate their effects on inflammatory mediators and fibrotic markers. In parallel, human renal proximal tubule epithelial cells (HK-2) were exposed to transforming growth factor-β1 (TGF-β1) to induce fibrosis in vitro . Subsequent molecular assays were performed to confirm the regulatory relationship between ATF4 and hexokinase II (HK-II), including verification of ATF4 binding to the HK2 promoter. Results: Western blotting and PCR analyses revealed a pronounced elevation of inflammatory cytokines, fibrotic markers, and ATF4 in the renal tissues of UUO mice compared with sham controls. Both in vitro and in vivo , ATF4 knockdown markedly mitigated tubular epithelial injury and fibrosis. Moreover, HK-II mRNA levels were significantly elevated in UUO renal tissues and in HK-2 cells stimulated with TGF-β1. Glycolytic inhibition effectively ameliorated tubular epithelial injury and fibrosis. Conclusion: In this study, we identified a marked induction of tubular ATF4 in mice subjected to UUO. Silencing ATF4 significantly mitigated renal tubulointerstitial fibrosis. Mechanistically, ATF4 was shown to act as a key glycolytic driver by transcriptionally upregulating hexokinase II. Collectively, these findings indicate that tubular ATF4 facilitates renal tubulointerstitial fibrosis through HK-II mediated glycolytic activation.


  • Metabolic Dysregulation of 27-Hydroxycholesterol Sensitizes Proximal Tubular Epithelial Cells to Ferroptosis in Ischemic Acute Kidney Injury

    by Yi-Lin Zhang, Xin-Yan Li, Tao-Tao Tang, Qin Yang, Bo Wang, Zuo-Lin Li, Yi Wen, Qiu-Li Wu, Lin-Li Lv, Ye Feng, et al.

    Key Points: Integrated single-cell spatial transcriptomics and metabolomics identified cholesterol reprogramming as a driver of ferroptosis in proximal tubules. Targeting the Cyp7b1/27-hydroxycholesterol axis efficiently alleviated ferroptosis-induced proximal tubule injury during ischemic AKI. Background: Cell death plays a pivotal role in ischemic AKI, with metabolic dysfunction emerging as a key contributor. However, the mechanism by which metabolism imbalance initiates renal tubular cell death is poorly understood. Methods: We combined single-cell spatial transcriptomics and metabolomics to characterize the function and metabolites of murine renal proximal cell subpopulations during ischemic AKI to CKD transition. Results: Ferroptosis was identified as the predominant mode of cell death in severely injured proximal straight tubules after AKI. Additional investigation revealed a critical deficiency in Cyp7b1, an enzyme responsible for metabolizing 27-hydroxycholesterol (27-HC) into 7 α ,27-dihydroxycholesterol, resulting in substantial 27-HC accumulation in proximal tubular cells during the early phase of ischemic AKI. Mechanistically, 27-HC acts as an endogenous ligand for estrogen receptor α , inducing downstream Hmox1 activation and thereby potentiating ferroptosis susceptibility in proximal tubular cells. Notably, adeno-associated virus–mediated Cyp7b1 overexpression in a murine ischemia-reperfusion injury model attenuated ferroptosis by enhancing 27-HC degradation, effectively mitigating ischemic AKI progression. These findings underscore the pivotal role of the Cyp7b1/27-HC axis in this pathologic context. Conclusions: Our study delineated a unique mechanism of Cyp7b1/27-HC axis in proximal tubular cell ferroptosis in early AKI.


  • Open Access

    Red Continuous KRT Effluent in a Patient with Acute Kidney Injury and Left Leg Pain

    by Zuo-Lin Li, Ji Zhang, Xiao-Liang Zhang

    Visual Abstract Export